Minhong Yan, Ph.D.

VP, Head of the BeiGene Institute

Dr. Minhong Yan joined BeiGene in September 2021 and is Vice President, Head of the BeiGene Institute. Prior to Joining BeiGene, he spent more than 20 years in the research division at Genentech, after obtaining his doctorate degree in molecular and cell biology from Case Western Reserve University. Dr. Yan brings rich expertise and experience in the biotech industry. He has initiated and led various drug programs for treating cancer, inflammation, and ocular diseases. He is the inventor of numerous U.S. patents.

Dr. Yan’s research interests span broad areas, including vascular biology, cancer immunology and antibody therapy. Intended to address fundamental questions with significant scientific and therapeutic ramifications, his research work has been published in high-impact journals including Nature, Science, Immunity, and Nature Immunology.

You are now leaving BeiGene Australia


BeiGene provides links to web sites of other organizations in order to provide visitors with certain information. A link does not constitute an endorsement of content, viewpoint, policies, products or services of that web site. Once you link to another web site not maintained byBeiGene Australia, you are subject to the terms and conditions of that web site, including but not limited to its privacy policy.

You will be redirected to

Click the link above to continue or CANCEL